Health Care Innovation
Health Care
Feed the Beast: Renewing the Prescription Drug User Fee Act (PDUFA)
Key Points: There is a crisis in biopharmaceutical R&D in all segments of the industry – large, mid-market, and new ventures. Much of the responsibility for this can be laid at the door of the Food and Drug Administration (FDA), which is slow to approve new drugs. The law that ...
Commentary
What I Learned At Haas Business School’s Health Care Conference
Theres a lot of entrepreneurial energy in the Bay Area, but Im always surprised at how much of it is directed towards health care. As Apothecary readers surely recognize, if we were to rank sectors where the government lies ready to crush the entrepreneurial spirit, health care and education must ...
Health Care
The Pacific Research Institute, Benjamin Rush Society, Docs 4 Patient Care, Galen Institute and Angel Raich File Amicus Brief Against ObamaCare
The Pacific Research Institute, Benjamin Rush Society, Docs 4 Patient Care, and the Galen Institute, today issued the following statements after filing an amicus brief in the U.S. Supreme Court supporting the 11th Circuit’s decision that the individual mandate under ObamaCare is unconstitutional. Sally C. Pipes, President and CEO of ...
Commentary
What Are The Costs And Benefits of Patents for Prescription Drugs?
On January 23, the Wall Street Journal hosted an interesting debate between Josh Bloom, Phd, of the American Council on Science and Health, and Dr. Else Torreele of the Open Society Foundation. (The link is here, and was free when I last checked. If it disappears behind a wall, the ...
Commentary
The road ahead on Obamacare repeal
There’s a case to be made that President Obama’s reform package is not just bad policy, it’s also of questionable constitutionality. As of this writing, 30 legal challenges to the health law have been launched involving states. Most notably, the U.S. Court of Appeals for the 11th Circuit in Atlanta ...
Commentary
End Obamacare’s taxes before they end lifesaving medical advances
Second of a series of three excerpts The Problem: Obamacare’s high taxes on pharmaceutical and medical device companies will deprive firms of capital that they need to be able to invest in new products. The Solution: Repeal Obamacare’s new taxes. Why It Will Work: Advances in medical science and technology ...
Commentary
Coal In Our Stockings: The Destruction of Medical Innovation
The holidays are fast approaching, and the “elves” are busy at the North Pole. No, not the presidential candidates. No, not the Capitol Hill pols. And no, not those unrelenting pursuers of objectivity and truth: the journalists. I refer instead to the bureaucrats, in particular those implementing the new “comparative ...
Health Care
The Federal Government’s Deeply Flawed System For Controlling Medicare Costs
Medicares hospital trust fund is set to be exhausted by 2024, according to the latest report from the programs trustees. Federal officials are understandably looking for easy ways to cut spending in the entitlement program in hopes of shoring up its finances. They believe theyve hit on one with a ...
Business & Economics
Comparative effectiveness reviews mean fewer cures
Elected officials have powerful incentives to spend, and the administrators of government agencies — always seeking to increase their budgets — are happy to oblige. But the federal budget is finite. There are equally-powerful incentives to create more programs, as politicians are driven to make more citizens dependent upon government. ...
Commentary
Two New Ventures Simplify Consumer-Driven Health Care
A friend of mine who made a lot of money use to tease me when I (constantly) expressed shock at how simple so many successful business ideas are. All great businesses are simple, he said. Here are two in the healthcare space: Bloom Health and ZocDoc. Although disrupting different parts ...
Feed the Beast: Renewing the Prescription Drug User Fee Act (PDUFA)
Key Points: There is a crisis in biopharmaceutical R&D in all segments of the industry – large, mid-market, and new ventures. Much of the responsibility for this can be laid at the door of the Food and Drug Administration (FDA), which is slow to approve new drugs. The law that ...
What I Learned At Haas Business School’s Health Care Conference
Theres a lot of entrepreneurial energy in the Bay Area, but Im always surprised at how much of it is directed towards health care. As Apothecary readers surely recognize, if we were to rank sectors where the government lies ready to crush the entrepreneurial spirit, health care and education must ...
The Pacific Research Institute, Benjamin Rush Society, Docs 4 Patient Care, Galen Institute and Angel Raich File Amicus Brief Against ObamaCare
The Pacific Research Institute, Benjamin Rush Society, Docs 4 Patient Care, and the Galen Institute, today issued the following statements after filing an amicus brief in the U.S. Supreme Court supporting the 11th Circuit’s decision that the individual mandate under ObamaCare is unconstitutional. Sally C. Pipes, President and CEO of ...
What Are The Costs And Benefits of Patents for Prescription Drugs?
On January 23, the Wall Street Journal hosted an interesting debate between Josh Bloom, Phd, of the American Council on Science and Health, and Dr. Else Torreele of the Open Society Foundation. (The link is here, and was free when I last checked. If it disappears behind a wall, the ...
The road ahead on Obamacare repeal
There’s a case to be made that President Obama’s reform package is not just bad policy, it’s also of questionable constitutionality. As of this writing, 30 legal challenges to the health law have been launched involving states. Most notably, the U.S. Court of Appeals for the 11th Circuit in Atlanta ...
End Obamacare’s taxes before they end lifesaving medical advances
Second of a series of three excerpts The Problem: Obamacare’s high taxes on pharmaceutical and medical device companies will deprive firms of capital that they need to be able to invest in new products. The Solution: Repeal Obamacare’s new taxes. Why It Will Work: Advances in medical science and technology ...
Coal In Our Stockings: The Destruction of Medical Innovation
The holidays are fast approaching, and the “elves” are busy at the North Pole. No, not the presidential candidates. No, not the Capitol Hill pols. And no, not those unrelenting pursuers of objectivity and truth: the journalists. I refer instead to the bureaucrats, in particular those implementing the new “comparative ...
The Federal Government’s Deeply Flawed System For Controlling Medicare Costs
Medicares hospital trust fund is set to be exhausted by 2024, according to the latest report from the programs trustees. Federal officials are understandably looking for easy ways to cut spending in the entitlement program in hopes of shoring up its finances. They believe theyve hit on one with a ...
Comparative effectiveness reviews mean fewer cures
Elected officials have powerful incentives to spend, and the administrators of government agencies — always seeking to increase their budgets — are happy to oblige. But the federal budget is finite. There are equally-powerful incentives to create more programs, as politicians are driven to make more citizens dependent upon government. ...
Two New Ventures Simplify Consumer-Driven Health Care
A friend of mine who made a lot of money use to tease me when I (constantly) expressed shock at how simple so many successful business ideas are. All great businesses are simple, he said. Here are two in the healthcare space: Bloom Health and ZocDoc. Although disrupting different parts ...
